InterCure
InterCure

InterCure

Pharmaceuticals
WebsiteInvestor RelationsSEC
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

$51.3M

Market Cap • 10/14/2026

1994

(32 years)

Founded

2019

(7 years ago)

IPO

NASDAQ

Listing Exchange

Flag of Israel

Israel

Country

Valuation

P/B

0,4

P/S

0,6

P/EBITDA

—

P/OCF

9,7

P/FCF

12,3

P/E

—

BVPS

11,4

EPS

—

Market Cap

Market Cap

51,3M

EV

92,7M

EV/Revenue

1,1

EV/EBITDA

-29,3

EV/EBIT

-10,8

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-0,9%

Total Yield

-0,9%

Payout

0%

Retained Earnings

-98,7M

Profitability

Gross Margin

12,3%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

0,1%

Capex/Revenue

1,3%

Capex/D&A

20,7%

Capex/OCF

21,1%

SBC/OCF

14,4%

% PPE

14,9%

% Goodwill

31,7%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

33,2%

CAGR Op. Income 5Y

-6,5%

CAGR Net Income 5Y

0,6%

CAGR EPS 5Y

-14%

CAGR OCF 5Y

16,5%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

1,5

Quick Ratio

1

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium